Drug–drug interactions of Z-338, a novel gastroprokinetic agent, with terfenadine, comparison with cisapride, and involvement of UGT1A9 and 1A8 in the human metabolism of Z-338

Autor: Furuta, Shigeru shigeru-furuta@zeria.co.jp, Kamada, Emiko¹, Omata, Takeshi¹, Sugimoto, Tohru¹, Kawabata, Yoshihiro¹, Yonezawa, Keiko², Wu, Xiaochun Cheryl³, Kurimoto, Tadashi¹

Publikováno v: European Journal of Pharmacology. Aug2004, Vol. 497 Issue 2, p223-231. 9p.

ATP-Dependent Transport of a Novel Thromboxane A2Receptor Antagonist, [2-(4-Chlorophenylsulfonylaminomethyl)-Indan-5-yl]Acetate (Z-335) and Its Xenobiotic Taurine Conjugate (Z-335-Tau) by Rat Bile Canalicular Membrane Vesicles

Autor: Kawabata, Yoshihiro, Kamada, Emiko, Furuta, Shigeru, Takei, Mineo, Kurimoto, Tadashi, Okudaira, Kazuho, Nishigaki, Ryuichiro

Publikováno v: Pharmaceutical Research; March 2004, Vol. 21 Issue: 3 p467-475, 9p

Mechanism of Hepatobiliary Transport of a Novel Thromboxane A2Receptor Antagonist, [2-(4-Chlorophenylsulfonylaminomethyl)indan-5-yl]acetate (Z-335), and its Xenobiotic Taurine Conjugate (Z-335-Tau) in Rats

Autor: Kawabata, Yoshihiro, Nakamura, Hideki, Kamada, Emiko, Furuta, Shigeru, Shinozaki, Yutaka, Kurimoto, Tadashi, Nishigaki, Ryuichiro

Publikováno v: Journal of Pharmaceutical Sciences; January 2003, Vol. 92 Issue: 1 p67-76, 10p

ATP-dependent transport of a novel thromboxane A2 receptor antagonist, [2-(4-chlorophenylsulfonylaminomethyl)indan-5-yl]acetate (Z-335) and its xenobiotic taurine conjugate (Z-335-Tau) by rat bile canalicular membrane vesicles.

Autor: Kawabata Y; Central Research Laboratories, ZERIA Pharmaceutical Co., Ltd., Oshikiri, Kohnan-Machi, Ohsato-Gun, Saitama 360-0111, Japan. yoshihiro-kawabata@zeria.co.jp, Kamada E, Furuta S, Takei M, Kurimoto T, Okudaira K, Nishigaki R

Publikováno v: Pharmaceutical research [Pharm Res] 2004 Mar; Vol. 21 (3), pp. 467-75.